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Summary
Depth of anaesthesia monitors usually analyse cerebral function with or without other physiological signals; non-
invasive monitoring of the measured cardiorespiratory signals alone would offer a simple, practical alternative. We
aimed to investigate whether such signals, analysed with novel, non-linear dynamic methods, would distinguish
between the awake and anaesthetised states. We recorded ECG, respiration, skin temperature, pulse and skin conduc-
tivity before and during general anaesthesia in 27 subjects in good cardiovascular health, randomly allocated to
receive propofol or sevoﬂurane. Mean values, variability and dynamic interactions were determined. Respiratory rate
(p = 0.0002), skin conductivity (p = 0.03) and skin temperature (p = 0.00006) changed with sevoﬂurane, and skin
temperature (p = 0.0005) with propofol. Pulse transit time increased by 17% with sevoﬂurane (p = 0.02) and 11%
with propofol (p = 0.007). Sevoﬂurane reduced the wavelet energy of heart (p = 0.0004) and respiratory (p = 0.02)
rate variability at all frequencies, whereas propofol decreased only the heart rate variability below 0.021 Hz
(p < 0.05). The phase coherence was reduced by both agents at frequencies below 0.145 Hz (p < 0.05), whereas the
cardiorespiratory synchronisation time was increased (p < 0.05). A classiﬁcation analysis based on an optimal set of
discriminatory parameters distinguished with 95% success between the awake and anaesthetised states. We suggest
that these results can contribute to the design of new monitors of anaesthetic depth based on cardiovascular signals
alone.
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Introduction
Because general anaesthesia involves loss of conscious-
ness, objective measures of depth of anaesthesia have
been focused mostly on EEG and EEG-derived mea-
surements, such as the evoked potentials from sound
or noxious stimuli [1–4]. Currently, there is no moni-
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tor of brain activity which meets the ideal of 100%
sensitivity and speciﬁcity for the awake and anaes-
thetised states. At least part of that deﬁciency may
arise because ‘anaesthesia vs awake’ may not be a bin-
ary set of conditions, and there may be neurophysio-
logical states in between that are nonetheless
apparently suitable for surgery [5, 6]. However, anaes-
thesia is also well known to inﬂuence the cardiovascu-
lar system. A multi-centre European study recently
assessed a combination of EEG parameters with mea-
sures of standard clinical cardiovascular parameters
(heart rate, blood pressure, change of heart rate and
blood pressure), for characterisation of the anaesthetic
state [7]. Even with this extensive combination of mea-
sures, the prediction probability of 88% for correctly
identifying the awake-to-anaesthetised transition still
fell far below the 100% ideal.
In standard clinical settings, like the above study,
most cardiovascular data are processed on a beat-by-
beat basis. But, if measured with a higher sampling
frequency (i.e. several samples per beat), the resultant
signals can provide more information relating to how
the system is changing (its dynamic properties such as
contributing oscillations and their coherence). In turn,
how these change with anaesthesia can be assessed.
There is also the possibility of including additional
non-invasive sensors, such as respiratory effort, skin
conductivity and skin temperature, all operated at a
high sampling frequency. We therefore propose that
simultaneous measurements of cardiovascular signals
in combination with dynamic analysis could have
potential clinical applications by providing the basis
for future depth of anaesthesia monitors.
As all cardiovascular variables vary with time, and
do so in a non-linear way, analyses that reﬂect this
non-linearity provide closer approximations to reality
[8, 9]. Dynamic analysis of blood ﬂow measurements
suggests that there are at least ﬁve characteristic oscil-
latory frequencies in the cardiovascular system, each
attributable to a particular physiological process,
including cardiac, respiratory, myogenic, sympathetic
and endothelial activities (Table 1). Complex oscilla-
tions can often be decomposed into their individual
oscillatory components using the Fourier transform.
Formally, however, this can be done only when the
signals are periodic, which implies that, for example,
mean heart rate is constant over time. In reality, this is
not the case. Therefore, we need methods that reveal
the time-variability of the constituent oscillations. A
method known as ‘wavelet analysis’ can decompose
oscillatory components locally in time to yield an opti-
mal time-frequency resolution [8, 10]. Furthermore,
techniques such as ‘wavelet phase coherence’ and ‘syn-
chronisation analysis’ can extract information about
the interactions between the underlying oscillatory
processes [9, 11].
We expected that anaesthesia would result in mul-
tiple changes in cardiovascular regulation that could be
revealed by applying novel non-linear dynamics meth-
ods to relevant signals. In addition, we proposed that,
when a large range of cardiovascular and autonomic
parameters are analysed, it would be possible to reli-
ably establish whether a patient was awake or anaes-
thetised. Thus, we tested two hypotheses: ﬁrst, that
there is a clear difference between the awake and
anaesthetised states; and second, that anaesthesia using
propofol would be demonstrably different (as assessed
by our methods) from anaesthesia using sevoﬂurane.
The choices of signals to be recorded, and the best
ways of creating the parameters for their interaction,
were guided by the results of earlier work on cardio-
vascular dynamics during anaesthesia in both rats [12,
13] and humans [14]. Core temperature [15] and skin
conductance [16] were added to the signals to be
recorded because these quantities are known to
undergo changes during anaesthesia.
Methods
The approvals of the relevant Research Ethics Com-
mittees were obtained before the study commenced.
Data collection took place before registration of studies
into trials registries was required. Subjects were invited
to participate and their written informed consent to
take part in the study was obtained on the day of sur-
gery. We studied healthy (ASA physical status 1 and
2) subjects aged between 18 and 60 years scheduled to
undergo minor to intermediate surgical procedures.
The exclusion criteria were: cardiovascular disease or
chronic obstructive pulmonary disease; ongoing cancer
or diabetes mellitus; allergy to anaesthetic drugs; or
taking medication that could inﬂuence the central ner-
vous system or cardiovascular dynamics. Subjects were
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ineligible if they had consumed caffeine-containing
drinks after 20:00 the previous day, or had taken a
sleeping pill the night before surgery.
A randomisation envelope was opened by study
personnel and the speciﬁed anaesthetic drug was pre-
pared, checked and labelled. No premedication was
given. Standard clinical anaesthetic monitoring was
attached (pulse oximetry, 3-lead electrocardiogram and
non-invasive arterial blood pressure). The sensors for
data recording were then applied as described below.
Intravenous access was obtained. After application and
calibration of the sensors, a stabilisation period was
allowed.
Once subjects conﬁrmed that they were comfort-
able, they were asked to relax, lie still, stay awake, and
not speak unless necessary for the duration of the
recordings. The ﬁrst set of recordings was then made
for approximately 30 minutes before anaesthesia. After
this, anaesthesia was induced with the drug dictated by
the randomisation procedure. In addition, a commer-
cial gas analyser displaying respired gas oxygen, carbon
dioxide and volatile anaesthetic agent concentrations
was used. For the propofol group, anaesthesia was
induced by infusing propofol until a simulated plasma
target concentration of 6.0 lg.ml1 was reached
(DiprifusorTM, target control system (TCI) Astra-
Zeneca, London, UK). A laryngeal mask airway was
inserted 2 min after the start of the infusion. After
insertion, the target concentration was reduced to
3.0 lg.ml1 and the infusion was maintained at this
rate throughout the measurement period [17, 18]. For
the sevoﬂurane group, subjects were asked to breathe
sevoﬂurane through a close-ﬁtting facemask until an
end-tidal concentration of 5% was reached. A laryngeal
mask airway was inserted, and then the sevoﬂurane
turned off until the end-tidal concentration fell to 2%.
The sevoﬂurane was then re-instituted to maintain the
end-tidal concentration at 2% throughout the measure-
ment period [19]. After a further stabilisation period
of 5–10 min, the second set of signal recordings took
place. Subjects breathed spontaneously during both
sets of recordings.
The signals were recorded using a system (Car-
dio&Brain Signals; Jozef Stefan Institute, Ljubljana,
Slovenia) specially designed for this study. The signals
were fed, via 24-bit A/D conversion at 1200 Hz, into a
purpose-built signal-conditioning unit and then stored
on a laptop computer.
The electrical activity of the heart was measured
with a 3-lead ECG system. To obtain well-deﬁned
ECG R-peaks, used to calculate heartbeat timing, the
standard electrodes were attached to the subject’s left
shoulder, right shoulder and lowest rib on the left
side of the body. The connecting cable was a
M1735A 3-lead ECG shielded cable (Philips Medizin
Systeme B€oblingen GmbH, Boeblingen, Germany) and
adapted to the Cardio&Brain Signals ECG input con-
nector.
Respiratory effort was recorded using a belt encir-
cling the subject’s chest, ﬁtted with a Biopac TSD201
Respiratory Effort Transducer (Biopac Systems Inc.,
Goleta, CA, USA).
Skin temperature was measured with two 8.5-mm
diameter, high-sensitivity, low heat capacity thermistors
taped to the skin: YSI 709B Thermilinear sensors (YSI
Inc., Yellow Springs, OH, USA). The ﬁrst (T1) was
positioned on the inside right ankle, over the medial
malleolus; and the second (T2) on the inside of the
right wrist, over the radial styloid process. Care was
taken to ensure good thermal contact between the sen-
sor and the skin.
Skin conductivity was measured using a pair of sil-
ver-plated electrodes taped to the ball and between the
distal and proximal joints of the right thumb. The
electrodes were adapted from the M1931A Reusable
EEG Adult Cup Electrode set of the Ag/AgCl electrode
system (Philips Medizin Systeme B€oblingen GmbH).
Electrical contact was facilitated by use of a standard
conductivity gel, e.g. Electro-Gel from Electro-Cap
International, Inc., Eaton, OH, USA. Conductivity was
determined from the DC current when 0.5 V was
applied between the electrodes. The maximum current
was limited to 125 lA.
The pulse generated by changes in arterial blood
pressure was measured on the subject’s right index
ﬁnger with a piezoelectric pressure transducer, the
MLT1010 Pulse Transducer (AD Instruments Pty Ltd,
Bella Vista, NSW, Australia). The volume of blood
ﬂowing into the ﬁnger tightened a cuff, generating a
pulse signal. As the output is a measure of dynamic
changes in pressure, the signal was integrated to obtain
a time series of blood pressure.
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The R-peaks of the ECG signal, and the maxima
of the respiration signal, were used as markers for car-
diac and respiratory oscillations, respectively. In this
way, the heart rate variability and respiratory fre-
quency variability signals were obtained (Appendix
S1). The maxima and minima of the integrated pulse
signal represent the systolic and diastolic pressures,
respectively. We deﬁned the arrival times of the pulse
signal to the ﬁnger as the minima in the pressure; this
is not only the easiest part of the signal to recognise
and locate but is also the least distorted part of the
propagated wave [20]. The time delay between the
arrival time of the pressure pulse wave and its corre-
sponding R-peak was deﬁned as the pulse transit time.
To discern the frequency content of the cardiovas-
cular oscillations, we performed wavelet analysis on
the recorded signals. The Morlet mother wavelet [21]
was used to calculate the continuous wavelet trans-
form. The spectral range was then divided into the ﬁve
physiologically relevant frequency intervals [8, 22]
between 0.0095 and 2 Hz shown in Table 1. The
energy of each of the signals, including the variability
of the heart and respiration rates, was calculated
(Appendix S2) within these intervals.
Wavelet phase coherence was used for exploration
of the phase relationships at particular frequencies
between oscillations from pairs of separate signals [23,
24]. Generally, phase coherence was considered to exist
if the phase difference between two oscillations
remained constant throughout the whole time of obser-
vation; this suggested that the signals are regulated from
a common source, or that they are mutually synchro-
nised [25] (see Appendix S2 for details of how the
synchronisation and wavelet phase coherence were
calculated; the method of surrogates [26] was used to
test for signiﬁcance). Co-ordination between the heart
and respiration is known to exist at rest and during
anaesthesia [9, 11, 12, 27–31]. Speciﬁcally, we studied
the phase synchronisation between respiration and
heartbeat as analysed by the synchronisation index [8].
The synchronisation time for each subject was deﬁned
as the sum of the intervals during which the indices are
95% or above of perfect synchronisation for window
lengths of 6T for 1:n synchronisation and 8T for 2:n
synchronisation, where T is the average respiratory per-
iod. This choice of window length and the use of phase
gives the same relative period for all subjects, as opposed
to methods which are based on absolute time [30, 31].
We then calculated the change in synchronisation time
between the awake state and during anaesthesia.
The analyses were made in MATLAB (Math-
Works, Natick, MA, USA) and two types of
comparison were carried out. First, using a paired,
non-parametric (Wilcoxon signed-rank) test, we inves-
tigated the statistical differences between the extracted
parameters related to the awake and anaesthetised
states. Secondly, we tested statistical differences
between the extracted parameters relevant for the
anaesthetised state with each of the two agents, using
an unpaired Wilcoxon rank sum test. The signiﬁcance
level was set at p = 0.05. Wherever appropriate, the
signiﬁcance of dynamic parameters, like phase coher-
ence, was tested against properties extracted from sur-
rogate signals which were generated by randomising
the correlations between the two signals, thus making
them independent and phase incoherent, but preserv-
ing the statistical properties of each signal [26].
On the basis of parameters derived from the
recorded signals, and by applying automatic classiﬁca-
tion method, we classiﬁed subjects into groups or classes
associated with three distinct states: awake, anaes-
thetised with sevoﬂurane, and anaesthetised with propo-
fol. The classiﬁcation is a machine-learning process
which is reﬁned until it performs optimally. There are
many possible classiﬁcation schemata and training
methods [32–35]. We applied two different approaches.
First, we applied a method specially developed for this
study. It is a variant of distance-based classiﬁcation (see
below) that arose naturally in the present context. It
takes direct account of the physiological nature of the
Table 1 Frequency intervals and their associated
physiological activity.
Interval Frequency (Hz) Physiological origin
I 0.6–2.0 Heartbeat
II 0.145–0.6 Respiratory activity
III 0.052–0.145 Intrinsic myogenic activity
IV 0.021–0.052 Neurogenic (sympathetic)
activity
V 0.0095–0.021 NO-dependent endothelial
activity
NO, nitric oxide.
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extracted parameters and during classiﬁcation simulta-
neously optimises the distance measure. Secondly, to test
the strength of our new classiﬁcation method, we
applied standard classiﬁcation techniques and corre-
sponding methodology from the freely available open-
source software package WEKA [36].
We used an unpaired test (Kolmogorov–Smirnov
[37]) to determine whether there were signiﬁcant dif-
ferences between the classiﬁed groups. If the difference
for a pair of physiological variables was found to be
signiﬁcant (p < 0.05) these were considered as attri-
butes and were included in the discriminatory analysis.
The attributes, summarised in Table 2, were grouped
into mean values, wavelet powers and interactions; we
then went through a controlled cascade of reductions
and mergers of attribute sets to ﬁnd the most predic-
tive attributes (see online Appendix S3 for details on
ranking attributes).
We used a distance-based classiﬁcation technique,
called the nearest neighbour classiﬁer [31], where each
subject is assigned a vector x based on their measured
signals and derived values. The (squared) distance
between two subjects x1 and x2 is calculated as
D(x1,x2)
2 = (x1  x2)T A (x1  x2), where T indicates
the transpose of the original matrix. The distance mea-
sure (i.e. the entries in the positive symmetric matrix
A) is determined through a procedure described in
online Appendix S3, where further details are given
[38].
The results of a classiﬁer are assessed by inspecting
the ‘confusion matrix’ [38] (see Table A2 of the online
supplementary information). In brief, the confusion
matrix contrasts actual states/classiﬁcations (rows) with
classiﬁcations/states (columns) predicted by the classi-
ﬁer. The diagonal entries correspond to the number
(likelihood) of correct classiﬁcations and off-diagonal
entries to the number (likelihood) of misclassiﬁcations:
the likelihood entries in one row sum up to 100%.
Further details can be found in Appendix S3.
Results
We recruited 27 patients from two centres, Oslo
(n = 13) and Lancaster (n = 14). Of these, 12 were
anaesthetised with propofol and 15 with sevoﬂurane;
six patients received propofol in each of the two cen-
tres; eight received sevoﬂurane in Lancaster and seven
in Oslo. The subject characteristics are given in
Table 3.
An example of a set of recorded signals is given in
Fig. 1. We ﬁrst calculated their mean values across the
whole recording, as shown in Table 4. Each subject
Table 2 The attributes used in the vector-based dis-
criminatory analysis for the different subsets of data.
Roman numerals indicate frequency intervals (see
Table 1). The 12 most relevant attributes, used in the
optimised classiﬁcation calculation, appear shaded.
Mean values
subset
Wavelet powers
subset Interactions subset
Heart rate HRV energy II HRV-conductivity II
Respiratory rate HRV energy III HRV-conductivity III
Skin temperature HRV energy IV HRV-conductivity IV
Skin conductivity HRV energy V Conductivity-pulse I
Pulse transit time RFV energy III Conductivity-pulse III
Total HRV energy RFV energy IV Conductivity-pulse IV
Total RFV energy RFV energy V Conductivity-
temperature I
Total conductivity
energy
Conductivity
energy III
Conductivity-
temperature II
Total temperature
energy
Conductivity
energy IV
Pulse-temperature I
Conductivity
energy V
C-R synchronisation
time
Conductivity
energy VI
1:n synchronisation
window length
Temperature
energy III
2:n synchronisation
window length
Temperature
energy IV
Temperature
energy V
Temperature
energy VI
RFV, respiratory frequency variability; HFV, heart rate vari-
ability.
Table 3 Characteristics of the two groups. Values are number or mean (SD).
Group
Number of
subjects (M:F) Age; years Height; cm Weight; kg
Body mass
index; kg.m2
Sevoflurane 15 (8:7) 31.9 (9.4) 176.0 (11.5) 77.8 (12.3) 25.7 (5.0)
Propofol 12 (10:2) 38.5 (12.3) 178.9 (9.1) 78.6 (16.3) 24.0 (3.9)
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acted as his/her own control in terms of awake versus
anaesthetised. There was no statistically signiﬁcant dif-
ference between the awake measurements of the two
study groups, propofol and sevoﬂurane.
Neither anaesthetic agent caused a statistically sig-
niﬁcant change in the mean heart rate and there was
no signiﬁcant difference between the anaesthesia
groups; p values for all comparisons are shown in
Table 4. In contrast, sevoﬂurane caused a signiﬁcant
increase in respiratory rate compared both with base-
line and with propofol.
A signiﬁcant increase in skin temperature was
observed on both sites with both anaesthetic agents.
The mean values shown in Table 4 represent the mean
between the two measurement sites, on wrist and
ankle. There was no signiﬁcant difference between the
propofol and sevoﬂurane groups.
There was wide between-subject variation in
recorded skin conductivity, amounting to several
orders of magnitude. However, for all subjects, skin
conductivity was typically highest when the sensor was
ﬁrst attached, then fell during the period of awake
measurement, with rapid increases when the subject
was subjected to a stimulus such as noise, end of the
measurement, or the onset of the anaesthesia proce-
dure. Mean skin conductivity decreased during anaes-
thesia with both agents, though this was signiﬁcant
only for sevoﬂurane. There was no signiﬁcant
Table 6 Confusion matrix, giving the likelihoods of
correct and incorrect classiﬁcation into two states, for
the distance-based classiﬁcation as in Table 3, using an
optimal distance on 12 attributes.
Classified state
Awake Anaesthetised
Actual state
Awake 98% 2%
Anaesthetised 8% 92%
Table 4 Heart rate, respiratory rate, skin temperature, skin conductivity, pulse transit time, the mean wavelet energy
of the signals, the duration of cardiorespiratory synchronisation and the duration of the windows for 1:n and 2:n
cardiorespiratory synchronisation. Values are mean (SD).
Sevoflurane Propofol Comparison
Control Anaes p Control Anaes p pcontrols psevo.prop
HR; Hz 1.07 (0.16) 1.07 (0.15) 0.89 1.08 (0.18) 1.14 (0.20) 0.23 0.96 0.46
RR; Hz 0.22 (0.07) 0.37 (0.08) 0.0002 0.19 (0.05) 0.23 (0.05) 0.09 0.14 0.0002
STemp; °C 30.0 (0.9) 32.1 (1.2) 0.00006 30.2 (2.1) 31.9 (2.2) 0.0005 0.33 0.75
SCond; ms 2.09 (2.50) 1.34 (1.17) 0.03 2.26 (2.18) 1.67 (1.37) 0.18 0.69 0.29
PTT; s 0.18 (0.02) 0.21 (0.05) 0.02 0.18 (0.01) 0.2 (0.02) 0.007 0.17 0.68
Mean wavelet energy
HRV; Hz2 1.36 0.53 0.0004 0.98 0.47 0.11 0.07 0.98
RFV; Hz2 0.26 0.13 0.02 0.39 0.14 0.051 0.54 0.21
STemp; °C2 0.00002 0.00007 0.14 0.0002 0.0001 0.85 0.07 0.54
SCond; S2 0.09 0.0003 0.002 0.02 0.0003 0.003 0.75 0.61
C-R synch.; s 173 385 0.03 138 323 0.04 0.55 0.55
C-R 1:n synch. window; s 38.00 16.00 0.00006 36.41 27.67 0.0830 0.0596 0.000022
C-R 2:n synch. window; s 50.87 21.20 0.00006 48.50 36.83 0.0654 0.0824 0.000019
p values are provided for the comparisons between control and anaesthetised groups with each of the two anaesthetics, and in the
ﬁnal columns between the awake measurements for the two groups (pcontrols) and for the two anaesthetic agents (psevo.prop).
HR, heart rate; RR, respiratory rate; STemp, skin temperature; SCond, skin conductivity; PTT, pulse transit time; C-R synch,
duration of cardiorespiratory synchronisation.
Table 5 Confusion matrix, giving the likelihoods of
correct and incorrect classiﬁcation into three states for
distance-based classiﬁcation using an optimal distance
on 12 attributes.
Classified state
Awake
Anaes-
Sevoflurane
Anaes-
Propofol
Actual state
Awake 98% 0 2%
Anaes-Sevoflurane 8% 84% 8%
Anaes-Propofol 9% 11% 80%
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difference between the two agents with respect to this
decrease.
Anaesthesia caused a signiﬁcant increase in pulse
transit time (Table 4): 17% with sevoﬂurane and 11%
with propofol.
Wavelet analysis of oscillations in measured and
derived signals revealed the following results. Both
anaesthetic agents were associated with a decrease in
heart rate variability (Fig. 2); this was signiﬁcant across
all frequencies for sevoﬂurane, but only in frequency
interval V (0.0095–0.021 Hz) for propofol. Both agents
were associated with a decrease in respiratory fre-
quency variability, signiﬁcantly for sevoﬂurane and
close to signiﬁcance for propofol. There was no signiﬁ-
cant change in temperature variability for either agent.
However, median skin conductivity variability
decreased considerably for both agents, though this fall
was small in comparison with the between-subject
variation in mean values at baseline.
Furthermore, we observed that the heartbeat and
breathing entered periods of synchronisation, whereby
a ﬁxed number of beats occurred for each breathing
cycle, as had been demonstrated previously [27–31].
The total synchronisation time was found to increase
with both anaesthetics, whereas the 1:n and 2:n syn-
chronisation windows decreased signiﬁcantly only with
sevoﬂurane, thus showing signiﬁcant difference in the
effects of the two anaesthetics. In contrast, the differ-
ence in the synchronisation time between the two
anaesthetics was not signiﬁcant (Table 4).
Figure 3 shows the phase coherence between pairs
of the cardiovascular and respiratory signals in the
awake and anaesthetised states. Frequencies where the
change is signiﬁcant are shaded; for example, section
Table 7 Confusion matrix giving both the numbers
and likelihoods of correct and incorrect classiﬁcations
into three states, for the distance-based classiﬁcation as
in Table 3, using an optimal distance on 12 attributes.
The numbers have been obtained using leave-one-out
cross-validation (as opposed to repeated 50% hold-out
for Tables 3 and 4).
Classified state
Awake
Anaes-
Sevoflurane
Anaes-
Propofol
Actual state
Awake 100% 0 0
Anaes-Sevoflurane 7% 93% 0
Anaes-Propofol 0 0 100%
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Figure 1 Example of a short segment of signals recorded during anaesthesia (from top to bottom): electrical activity
of the heart (ECG); respiration as a percentage of the sensor range; skin conductivity; skin temperature from the
wrist (upper) and ankle (lower) and piezoelectric pulse.
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(d) of Fig. 3 shows the phase coherence between skin
conductivity and the pulse pressure signal. Both
sevoﬂurane and propofol caused a signiﬁcant reduction
in phase coherence below 0.145 Hz. In effect, the
coherence between these two signals when awake was
lost during anaesthesia.
The attributes used in the classiﬁcation analysis to
distinguish the awake from the anaesthetised state
appear in Table 2. The controlled cascade of reduc-
tions and mergers of attribute sets revealed a very efﬁ-
cient set of 12 attributes, which appear shaded in
Table 2 (see Appendix S3 online for details on ranking
attributes). By using the obtained optimal distance in
classiﬁcation with repeated hold-out validation, we
obtained a classiﬁcation accuracy of A3 = 90% with
the corresponding confusion matrix expressed in per-
centages in Table 5. In this table, the sum in a hori-
zontal row is 100% and the values on the diagonal
present correct classiﬁcations. Thus, 98% of awake
subjects were classiﬁed as awake and 2% as anaesthe-
tised with propofol. The classiﬁcation resulted in
recognising 84% of subjects anaesthetised with sevo-
ﬂurane correctly, whereas 8% were wrongly classiﬁed
as awake and another 8% as anaesthetised with propo-
fol. Lastly, of all subjects anaesthetised with propofol,
80% were classiﬁed correctly, 9% were classiﬁed as
awake and 11% as anaesthetised with sevoﬂurane.
Further description of the confusion matrix is given in
Appendix S3.
Merging the two anaesthetised states into one
state, yielded a classiﬁcation accuracy of A2 = 95%, as
summarised in the confusion matrix given in Table 6.
The classiﬁcation with the optimal distance and simple
leave-one-out cross-validation gives an accuracy
A3 = 98%, as summarised in the confusion matrix in
Table 7.
Details of the classiﬁcation analysis and results are
summarised in Appendix 3.
Discussion
The use of cardiovascular and autonomic signs to assess
depth of anaesthesia is not new; scores based on such
signs have been used in the research context since the
1980s [39–43], and the signs are still in clinical use [15].
In particular, heart rate variability, analysed either via
its frequency content [39] or various entropy measures
[44], in combination with blood pressure or cardiores-
piratory co-ordination [30, 31], have been used to assess
the activity of the autonomic nervous system as an indi-
cator of the state of anaesthesia. However, our results
yield insights into the changes in cardiovascular interac-
tions revealed by the application of recently-introduced
non-linear dynamic of analytical methods [9]. They
were applied, not just to one or two signals, but to sev-
eral simultaneously measured signals, and a classiﬁca-
tion method was used for optimal combination of all
the inferred parameters. A number of distinct changes
between the awake and anaesthetised states, and
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between the effects of the two anaesthetics, are thus
demonstrated. The study can draw two types of
conclusion: (a) on which physiological parameters
change signiﬁcantly during anaesthesia with either
propofol or sevoﬂurane; and (b) on which of the
extracted parameters can be used to discriminate the
data optimally to classify each of the subject’s measured
states.
Respiratory rate, skin temperature and pulse tran-
sit time increased during anaesthesia, whereas skin
conductivity and the derived quantities of heart rate
and respiratory rate variability both decreased. We
have shown that anaesthesia is associated with a conse-
quent reduction in the phase coherence, whereas car-
diorespiratory phase synchronisation increases; the
tendency for heart rate and respiratory rate to syn-
chronise under anaesthesia is previously unreported
for sevoﬂurane in humans. Furthermore, there was a
general reduction in phase coherence between the
various signals under anaesthesia and a clear difference
between the effects of the two anaesthetics.
In earlier studies, heart rate variability has mostly
been assessed using Fourier-based methods of spectral
analysis, which typically deal with high-frequency
(approx. 0.02–0.15 Hz) and low-frequency (approx.
0.15–0.4 Hz) bands. While there are a number of
theories for the physiological basis of the activities at
different frequencies, the move from what might be
termed a ‘cardiocentric’ view of the circulation to one
which encompasses the role of vascular regulation is
well supported by our previous work [8, 22]. Decreases
have been reported in these bands [44], which are
approximately equivalent to bands III and IV in our
study (Table 1).
Other new ﬁndings in this study arise from the
use of wavelet analysis to further reﬁne the results of a
number of physiological responses to anaesthesia.
Wavelet analyses enabled us to choose window sizes
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according to the time scales of interest and to identify
the physiological processes associated with particular
frequency bands (see Table 1). We have observed for
the ﬁrst time a statistically signiﬁcant decrease in heart
rate variability wavelet energy in the lower frequency
band V (0.0095–0.021 Hz) between the awake and
anaesthetised states with both anaesthetic agents
(Fig. 2a). In microvascular studies, activity in these
bands has been shown to be associated with nitric
oxide-related endothelial activity [45, 46].
There was a signiﬁcant increase in the mean respi-
ratory rate with sevoﬂurane. Propofol resulted only in
a slight increase in respiratory frequency, which was
signiﬁcantly lower than the average respiratory fre-
quency during sevoﬂurane anaesthesia. Furthermore,
the total energy of respiratory frequency variability
decreased with anaesthesia, signiﬁcantly with sevoﬂu-
rane (p = 0.02) and borderline signiﬁcantly with
propofol, (p = 0.051). The wavelet energy of respira-
tory frequency variability has not previously been stud-
ied during anaesthesia.
In relation to interactions, we observed an
increased tendency for the heart and respiration to
synchronise during anaesthesia with both sevoﬂurane
and propofol. This was reported in an earlier study of
cardiorespiratory interactions using propofol in
humans [14], and has been observed in rats [12]
anaesthetised with ketamine, but has not previously
been reported for sevoﬂurane in humans. Further,
when wavelet phase coherence was used to check for
signiﬁcant phase relationships between the oscillations
in the various signals, we observed that this relation-
ship changed when a person is anaesthetised. For
instance, between the conductivity and pulse signals,
there is a reduction in the phase coherence at frequen-
cies below 0.145 Hz for both anaesthetic agents. The
observed reduction agrees with the general picture that
interactions within the cardiovascular system are
reduced by anaesthesia because communication
through the neuronal network is restricted.
In the discriminatory classiﬁcation, we studied
separately the classiﬁcations based on the following
parameters obtained from analysis: (a) the mean values
and total wavelet energies; (b) the wavelet energy spec-
tra for individual frequency bands; and (c) the wavelet
phase coherence and synchronisation values. In each
of the three categories, an optimal set was selected and
the classiﬁcation success rate was evaluated. Using the
mean data alone, we were able to categorise subjects
into three groups (awake, anaesthetised with sevoﬂu-
rane, anaesthetised with propofol) with a 86% success
rate, and into two groups (awake or anaesthetised)
with a 90% success rate. The changes in the oscilla-
tions and their interactions induced by the anaesthetics
are evidently not robust enough to provide measures
of state by themselves. However, a combination of the
mean values, oscillations and interaction data
improved the success rate of categorising into three
groups (awake, anaesthetised with sevoﬂurane, anaes-
thetised with propofol) to 90%, whereas for classifying
into two groups (awake, anaesthetised) the optimisa-
tion of classiﬁcation improved to 95%.
The main aims of the study were to understand
the effects of the two anaesthetics and, in particular, to
establish which physiological parameters change most
signiﬁcantly on entering anaesthesia. Thus, we hoped
to identify which parameters are potentially the most
useful in discriminating between the awake and anaes-
thetised states. These were found to be: the mean res-
piratory rate; the total wavelet energy of the heart rate
variability; the total wavelet energy of the respiratory
frequency variability signal; the mean temperature; the
mean synchronisation time; the window lengths for 1:
n and 2:n synchronisation; the phase coherence
between pulse and temperature in frequency interval I;
the wavelet energy in frequency intervals III and IV of
heart rate variability; the wavelet energy in frequency
interval V of the respiratory frequency variability; and
the wavelet energy of frequency interval VI of the con-
ductivity signal. Coherence and synchronisation analy-
ses remain candidates for inclusion within a future
novel method of anaesthesia monitoring, but do not
provide robust enough measures for use by themselves.
Our result of 95% prediction of the awake-to-
anaesthetised transition compares favourably with the
88% prediction based on a combination of EEG and
static physiological variables [7]. Once the number of
data sets for classiﬁcation is larger (several hundreds),
one could expect prediction approaching 100%.
We have selected a relatively simple model of anaes-
thesia – to evaluate the effects of each of the two drugs
as speciﬁcally as possible. However, to evaluate the
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practical applicability of the presented results, a study
with more realistic conditions need to be performed.
This should include: subjects with varying drug concen-
trations during anaesthesia, or different combination of
anaesthetics; subjects who are receiving neuromuscular
blocking drugs in addition to general anaesthetics; and
subjects whose lungs are being mechanically ventilated,
all preferably with continuous recordings during surgery
and emergence from anaesthesia.
In summary, we have presented thorough investiga-
tions of the effects of sevoﬂorane and propofol on car-
diovascular regulation. Subtle differences in the effects
of these two drugs, which are known to operate via dif-
ferent cellular mechanisms, were identiﬁed for car-
diorespiratory interactions. Furthermore, a number of
relevant parameters were extracted and those that con-
tributed to higher classiﬁcation rates, in either two
groups (control and anaesthetised) or three groups
(control, sevoﬂurane and propofol) were discussed.
Although we did not use measures of depth of anaesthe-
sia other than end-tidal sevoﬂurane and target propofol
concentrations, we believe that our study paves the way
to a modern depth of anaesthesia monitor utilising
simultaneous recordings of cardiovascular signals, with
on-line non-linear analysis and classiﬁcation, able to
monitor robustly the state and depth of anaesthesia.
Future work could usefully validate the novel algorithm
on data from a new, larger group of patients and incor-
porate an additional measure of depth of anaesthesia
such as the use of the isolated forearm technique. We
would also advocate further studies to improve the sen-
sitivity and speciﬁcity of each of our components for the
composite analyses. It has, for instance, been shown that
reﬁnement of the raw skin conductivity values into anal-
yses of frequency of minor sweat bursts increases the
precision of the skin conductivity tool [47].
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Table S1. The parameters used in the vector-based
discriminatory analysis for the different subsets of
data.
Table S2. Five confusion matrices, giving the likeli-
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the 3 groups of subjects, for ﬁve different sets of para-
meters.
Figure S1. Illustration of the vector-based discrimina-
tory analysis.
Figure S2. J48 decision tree obtained from the com-
plete dataset.
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